253 related articles for article (PubMed ID: 12019102)
21. Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial.
Raborn GW; McGaw WT; Grace M; Percy J; Samuels S
Oral Surg Oral Med Oral Pathol; 1989 Jun; 67(6):676-9. PubMed ID: 2740091
[TBL] [Abstract][Full Text] [Related]
22. Herpes labialis in skiers: randomized clinical trial of acyclovir cream versus placebo.
Raborn GW; Martel AY; Grace MG; McGaw WT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Dec; 84(6):641-5. PubMed ID: 9431533
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of herpes labialis with topical acyclovir.
Fiddian AP; Yeo JM; Stubbings R; Dean D
Br Med J (Clin Res Ed); 1983 May; 286(6379):1699-701. PubMed ID: 6405939
[TBL] [Abstract][Full Text] [Related]
24. Acyclovir cream prevents clinical and thermographic progression of recrudescent herpes labialis beyond the prodromal stage.
Biagioni PA; Lamey PJ
Acta Derm Venereol; 1998 Jan; 78(1):46-7. PubMed ID: 9498027
[TBL] [Abstract][Full Text] [Related]
25. Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.
Hull CM; Levin MJ; Tyring SK; Spruance SL
Antimicrob Agents Chemother; 2014; 58(3):1273-8. PubMed ID: 24342632
[TBL] [Abstract][Full Text] [Related]
26. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
Baker D; Eisen D
Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
[TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
[TBL] [Abstract][Full Text] [Related]
28. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.
Rooney JF; Straus SE; Mannix ML; Wohlenberg CR; Alling DW; Dumois JA; Notkins AL
Ann Intern Med; 1993 Feb; 118(4):268-72. PubMed ID: 8380540
[TBL] [Abstract][Full Text] [Related]
29. Treatment of recurrent herpes simplex labialis with oral acyclovir.
Spruance SL; Stewart JC; Rowe NH; McKeough MB; Wenerstrom G; Freeman DJ
J Infect Dis; 1990 Feb; 161(2):185-90. PubMed ID: 2153735
[TBL] [Abstract][Full Text] [Related]
30. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis.
Horwitz E; Pisanty S; Czerninski R; Helser M; Eliav E; Touitou E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Jun; 87(6):700-5. PubMed ID: 10397661
[TBL] [Abstract][Full Text] [Related]
31. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.
Spruance SL; Jones TM; Blatter MM; Vargas-Cortes M; Barber J; Hill J; Goldstein D; Schultz M
Antimicrob Agents Chemother; 2003 Mar; 47(3):1072-80. PubMed ID: 12604544
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial.
Bieber T; Chosidow O; Bodsworth N; Tyring S; Hercogova J; Bloch M; Davis M; Lewis M; Boutolleau D; Attali P;
J Drugs Dermatol; 2014 Jul; 13(7):791-8. PubMed ID: 25007361
[TBL] [Abstract][Full Text] [Related]
33. Herpes Labialis: An Update.
Leung AKC; Barankin B
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
[TBL] [Abstract][Full Text] [Related]
34. Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir.
Spruance SL; Crumpacker CS; Schnipper LE; Kern ER; Marlowe S; Arndt KA; Overall JC
Antimicrob Agents Chemother; 1984 May; 25(5):553-5. PubMed ID: 6732224
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.
Spruance SL
J Med Virol; 1993; Suppl 1():27-32. PubMed ID: 8245889
[TBL] [Abstract][Full Text] [Related]
36. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double-blind, dose-ranging, placebo-controlled, multicenter trial.
Spruance SL; Rowe NH; Raborn GW; Thibodeau EA; D'Ambrosio JA; Bernstein DI
J Infect Dis; 1999 Feb; 179(2):303-10. PubMed ID: 9878012
[TBL] [Abstract][Full Text] [Related]
37. No significant analgesic benefit of adding lidocaine 2% to aciclovir 5% cream as treatment of episodes of herpes labialis.
Bodsworth NJ; Bayerl C; Cunningham A; Silny W
Herpes; 2003 Aug; 10(2):53-4. PubMed ID: 14577955
[No Abstract] [Full Text] [Related]
38. Topical acyclovir in the management of recurrent herpes labialis.
Fiddian AP; Ivanyi L
Br J Dermatol; 1983 Sep; 109(3):321-6. PubMed ID: 6351894
[TBL] [Abstract][Full Text] [Related]
39. Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit.
Spruance SL; Crumpacker CS
Am J Med; 1982 Jul; 73(1A):315-9. PubMed ID: 6285721
[TBL] [Abstract][Full Text] [Related]
40. Treatment of herpes labialis.
Fiddian AP; Yeo JM; Clark AE
J Infect; 1983 May; 6(1 Suppl):41-7. PubMed ID: 6350474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
